Akero Therapeutics, based in San Francisco, is a leading cardio-metabolic biotechnology company focused on developing innovative treatments for non-alcoholic steatohepatitis (NASH).
The company's mission is to create transformational therapies that address the unmet medical needs of individuals suffering from NASH, a serious liver condition with limited treatment options.
Generated from their website's infomation